T2 Biosystems, Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on July 29, 2024, at 4:00 P.M. The notice pertains to the Form S-3, which is typically used by companies to register securities for potential future offerings. The effectiveness of the form indicates that the SEC has reviewed and accepted the company's registration statement, allowing T2 Biosystems to proceed with the issuance of securities as outlined in the filing. The company's CIK number is 0001492674, and the file number associated with this notice is 333-280922.

T2 Biosystems, Inc., a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on July 29, 2024, at 4:00 P.M. The notice pertains to the Form S-3, which is typically used by companies to register securities for potential future offerings. The effectiveness of the form indicates that the SEC has reviewed and accepted the company's registration statement, allowing T2 Biosystems to proceed with the issuance of securities as outlined in the filing. The company's CIK number is 0001492674, and the file number associated with this notice is 333-280922.